Blood Pressure Trajectories and Associations With Treatment Intensification, Medication Adherence, and Outcomes Among Newly Diagnosed Coronary Artery Disease Patients

被引:40
作者
Maddox, Thomas M. [1 ]
Ross, Colleen [2 ]
Tavel, Heather M. [2 ]
Lyons, Ella E. [2 ]
Tillquist, Maggie [3 ]
Ho, P. Michael
Rumsfeld, John S.
Margolis, Karen L. [4 ]
O'Connor, Patrick J. [4 ]
Selby, Joe V. [5 ]
Magid, David J. [2 ]
机构
[1] Univ Colorado Denver, Denver VAMC, Cardiol Sect 111B, Denver, CO 80220 USA
[2] Kaiser Permanente Colorado, Inst Hlth Res, Denver, CO USA
[3] Univ Colorado Denver, Sch Med, Denver, CO 80220 USA
[4] Hlth Partners Res Fdn, Minneapolis, MN USA
[5] Kaiser Permanente No Calif, Oakland, CA USA
来源
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES | 2010年 / 3卷 / 04期
关键词
hypertension; epidemiology; health services research; myocardial infarction; mortality; NONADHERENCE;
D O I
10.1161/CIRCOUTCOMES.110.957308
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Blood pressure (BP) control among coronary artery disease patients remains suboptimal in clinical practice, potentially due to gaps in treatment intensification and medication adherence. However, longitudinal studies evaluating these relationships and outcomes are limited. Methods and Results-We assessed BP trajectories among health maintenance organization patients with hypertension and incident coronary artery disease. BP trajectories were modeled over the year after coronary artery disease diagnosis, stratified by target BP goal. Treatment intensification (increase in BP therapies in the setting of an elevated BP), medication adherence (percentage of days covered with BP therapies), and outcomes (all-cause mortality, myocardial infarction, and revascularization) were evaluated in multivariable models: 9569 patients had a <140/90 mm Hg BP target and 12 861 had a <130/80 mm Hg BP target. Within each group, 4 trajectories were identified: good, borderline, improved, and poor control. After adjustment, increasing BP treatment intensity was significantly associated with better BP trajectories in both groups. Medication adherence had inconsistent effects. There were no significant differences in combined outcomes by BP trajectory, but among the diabetes and renal disease cohort, borderline control patients were less likely to have myocardial infarction (odds ratio, 0.61; 95% confidence interval, 0.40-0.93), and good control patients were less likely to have myocardial infarction (odds ratio, 0.53; 95% confidence interval, 0.34-0.84) or a revascularization procedure (odds ratio, 0.66; 95% confidence interval, 0.47-0.93) compared with poor control patients. Conclusions-In this health maintenance organization population, treatment intensification but not medication adherence significantly affects BP trajectories in the year after coronary artery disease diagnosis. Better BP trajectories are associated with lower rates of myocardial infarction and revascularization. (Circ Cardiovasc Qual Outcomes. 2010;3:347-357.)
引用
收藏
页码:347 / 357
页数:11
相关论文
共 17 条
  • [11] Medication adherence and the patient with coronary artery disease: challenges for the practitioner
    Maddox, Thomas M.
    Ho, P. Michael
    [J]. CURRENT OPINION IN CARDIOLOGY, 2009, 24 (05) : 468 - 472
  • [12] Blood pressure control and improved cardiovascular outcomes in the international verapamil SR-trandolapril study
    Mancia, Giuseppe
    Messerli, Franz
    Bakris, George
    Zhou, Qian
    Champion, Annette
    Pepine, Carl J.
    [J]. HYPERTENSION, 2007, 50 (02) : 299 - 305
  • [13] Adherence to Antihypertensive Medications and Cardiovascular Morbidity Among Newly Diagnosed Hypertensive Patients
    Mazzaglia, Giampiero
    Ambrosioni, Ettore
    Alacqua, Marianna
    Filippi, Alessandro
    Sessa, Emiliano
    Immordino, Vincenzo
    Borghi, Claudio
    Brignoli, Ovidio
    Caputi, Achille P.
    Cricelli, Claudio
    Mantovani, Lorenzo G.
    [J]. CIRCULATION, 2009, 120 (16) : 1598 - U82
  • [14] Comparing Methods of Measuring Treatment Intensification in Hypertension Care
    Rose, Adam J.
    Berlowitz, Dan R.
    Manze, Meredith
    Orner, Michelle B.
    Kressin, Nancy R.
    [J]. CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2009, 2 (04): : 385 - U178
  • [15] Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension
    Rothwell, Peter M.
    Howard, Sally C.
    Dolan, Eamon
    O'Brien, Eoin
    Dobson, Joanna E.
    Dahlof, Bjorn
    Sever, Peter S.
    Poulter, Neil R.
    [J]. LANCET, 2010, 375 (9718) : 895 - 905
  • [16] AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update
    Smith, Sidney C., Jr.
    Allen, Jerilyn
    Blair, Steven N.
    Bonow, Robert O.
    Brass, Lawrence M.
    Fonarow, Gregg C.
    Grundy, Scott M.
    Hiratzka, Loren
    Jones, Daniel
    Krumholz, Harlan M.
    Mosca, Lori
    Pasternak, Richard C.
    Pearson, Thomas
    Pfeffer, Marc A.
    Taubert, Kathryn A.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (10) : 2130 - 2139
  • [17] Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis
    Webb, Alastair J. S.
    Fischer, Urs
    Mehta, Ziyah
    Rothwell, Peter M.
    [J]. LANCET, 2010, 375 (9718) : 906 - 915